Nobleoak Life (ASX:NOL) EBIT: A$0.0 Mil (TTM As of Dec. 2025)


ASX:NOL Nobleoak Life Ltd ASX:NOL
52 GF Score
Price A$1.19
GF Value A$1.76
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nobleoak Life EBIT?

Nobleoak Life ASX:NOL -7.42% 52 EBIT is A$0.0 Mil as of Dec. 2025. GuruFocus rates ASX:NOL with a GF Score™ of 52/100 and a GF Value™ of A$1.76 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Nobleoak Life's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was A$0.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nobleoak Life's annualized ROC % for the quarter that ended in Dec. 2025 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nobleoak Life's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.00%.


Nobleoak Life  (ASX:NOL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nobleoak Life's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=EBIT * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=0 * ( 1 - 30.43% )/( (366.21635 + 437.2926)/ 2 )
=0/401.754475
=0.00 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Balance Sheet Cash And Cash Equivalents - 5% * Revenue )
=567.292 - 113.087 - ( 85.545 - 5% * -48.873 )
=366.21635

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Balance Sheet Cash And Cash Equivalents - 5% * Revenue )
=600.629 - 109.718 - ( 66.225 - 5% * 252.132 )
=437.2926

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nobleoak Life's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=0/56.958
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobleoak Life EBIT Related Terms


Nobleoak Life EBIT Historical Data

* Premium members only.

The historical data trend for Nobleoak Life's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobleoak Life EBIT Chart

Nobleoak Life Annual Data
Trend Jun22 Jun23 Jun24 Jun25
EBIT
0.00 0.00 18.32 47.47

Nobleoak Life Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:NOL vs AFL, MET, PRU: EBIT Comparison

For the Insurance - Life subindustry, Nobleoak Life's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobleoak Life EV-to-EBIT vs Insurance Industry

For the Insurance industry and Financial Services sector, Nobleoak Life's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nobleoak Life's EV-to-EBIT falls into.


ASX:NOL
52GF Score
Nobleoak Life Ltd ASX:NOL
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nobleoak Life EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of A$0.0 Mil mean?
Nobleoak Life (ASX:NOL) has a EBIT of A$0.0 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nobleoak Life.
Is Nobleoak Life's EBIT too high?
Nobleoak Life's current EBIT is A$0.0 Mil. Overall, Nobleoak Life has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's EBIT compare to AFL and MET?
Nobleoak Life's EBIT of A$0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Insurance company?
A good EBIT depends on the Insurance industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nobleoak Life. Nobleoak Life's current EBIT is A$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Significantly Undervalued. The stock's GF Value™ is A$1.76, compared to a current price of A$1.19 — trading 32.7% below its estimated fair value. The current EBIT is A$0.0 Mil. Nobleoak Life's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current EBIT is A$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nobleoak Life (ASX:NOL) Overvalued in 2026?

Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued. The current stock price of A$1.19 is trading 32.7% below its estimated GF Value™ of A$1.76. GuruFocus considers Nobleoak Life to be Significantly Undervalued.

Key valuation signals for ASX:NOL:

  • EBIT: A$0.0 Mil
  • GF Value™: A$1.76 vs. price of A$1.19 (32.7% below fair value)
  • GF Score™: 52/100 with 2 warning signs

No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nobleoak Life Business Description

Address 44 Market Street, Level 4, Sydney, NSW, AUS, 2000
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
52GF Score

Get the complete analysis for ASX:NOL

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.19
Price
A$1.76
GF Value